tiprankstipranks
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market
ALLO
Allogene Therapeutics
RESEARCH TOOLSreports
Want to see ALLO full AI Analyst Report?

Allogene Therapeutics (ALLO) Stock News & Sentiment

1,758 Followers
Allogene Therapeutics Prices Large Common Stock Offering
Premium
Company Announcements
Allogene Therapeutics Prices Large Common Stock Offering
20d ago
8K
ALLO
Allogene Therapeutics Launches New Underwritten Common Stock Offering
Premium
Company Announcements
Allogene Therapeutics Launches New Underwritten Common Stock Offering
22d ago
8K
ALLO
Allogene Therapeutics: Strong ALPHA3 Futility Data and Favorable Safety Profile Support Buy Rating and Blockbuster Potential for Cema-cel in LBCL
Premium
Ratings
Allogene Therapeutics: Strong ALPHA3 Futility Data and Favorable Safety Profile Support Buy Rating and Blockbuster Potential for Cema-cel in LBCL
22d ago
ALLO
Allogene Highlights Positive Interim ALPHA3 CAR T Data
Premium
Company Announcements
Allogene Highlights Positive Interim ALPHA3 CAR T Data
22d ago
8K
ALLO
Allogene Therapeutics Faces Trial Setback as ALLO-647 Halt Raises Lymphodepletion and Regulatory Timeline Risks
Premium
Company Announcements
Allogene Therapeutics Faces Trial Setback as ALLO-647 Halt Raises Lymphodepletion and Regulatory Timeline Risks
2M ago
ALLO
Allogene Therapeutics Banks on 2026 Trial Catalysts
Premium
Company Announcements
Allogene Therapeutics Banks on 2026 Trial Catalysts
2M ago
ALLO
ALLO Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ALLO Earnings this Week: How Will it Perform?
2M ago
ALLO
More ALLO News >

ALLO News on the Web

ALLO-329’s Dual CAR T Approach Targets Autoimmune Disease Market with Preclinical Success
Market Chameleon
Neutral
Allogene Therapeutics price target lowered to $11 from $12 at H.C. Wainwright
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Allogene Therapeutics (ALLO), Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)
TipRanks News
Neutral
Allogene Therapeutics upgraded to Neutral from Underweight at JPMorgan
TipRanks News
Neutral
Allogene Therapeutics Prices Large Common Stock Offering
TipRanks News
Neutral
Allogene Therapeutics price target raised to $10 from $6 at Jefferies
TipRanks News
Bullish
Unusually active option classes on open April 15th
TipRanks News
Neutral
Allogene Prices $175 Mln Offering At $2 Per Share; Stock Down
rttnews
Bearish

News Score - Last 7 Days

Very Positive
ALLO
Sector Average
Media Buzz
This Week19 articles
Weekly Average4.75 articles
News Sentiment
This Week88%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALLO’s Media Buzz Sentiment?
19 articles about ALLO were published this week. In an average week, 4.75 articles are published.
    What is ALLO’s weekly average amount of articles?
    In an average week, 4.75 articles about ALLO are published.
      What is ALLO’s News Sentiment?
      88% of articles about ALLO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week